Erech Finance Cahalacha Ltd (EFNC) - Total Liabilities

Latest as of December 2023: ILA19.14 Million ILA ≈ $51.31K USD

Based on the latest financial reports, Erech Finance Cahalacha Ltd (EFNC) has total liabilities worth ILA19.14 Million ILA (≈ $51.31K USD) as of December 2023. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Erech Finance Cahalacha Ltd growing its equity to track the company's year-over-year net asset growth rate.

Erech Finance Cahalacha Ltd - Total Liabilities Trend (2014–2023)

This chart illustrates how Erech Finance Cahalacha Ltd's total liabilities have evolved over time, based on quarterly financial data. See Erech Finance Cahalacha Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Erech Finance Cahalacha Ltd Competitors by Total Liabilities

The table below lists competitors of Erech Finance Cahalacha Ltd ranked by their total liabilities.

Company Country Total Liabilities
Fimperkasa Utama Tbk PT
JK:FIMP
Indonesia Rp5.07 Billion
Midwich Group PLC
LSE:MIDW
UK GBX465.24 Million
Northern 2 Vct Plc
LSE:NTV
UK GBX185.00K
Heads UP Ventures Limited
NSE:HEADSUP
India Rs297.60 Million
Engineer Gold Mines Ltd
V:EAU
Canada CA$708.84K
FDM Group Holdings PLC
LSE:FDM
UK GBX37.56 Million
NO GRAVITY GAMES ZY -10
F:8YX
Germany €776.14K
ModuLink Inc.
NASDAQ:MDLK
USA $835.06K

Liability Composition Analysis (2014–2023)

This chart breaks down Erech Finance Cahalacha Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EFNC market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.53 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.42 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Erech Finance Cahalacha Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Erech Finance Cahalacha Ltd (2014–2023)

The table below shows the annual total liabilities of Erech Finance Cahalacha Ltd from 2014 to 2023.

Year Total Liabilities Change
2023-12-31 ILA19.14 Million
≈ $51.31K
-53.07%
2022-12-31 ILA40.78 Million
≈ $109.34K
-20.63%
2021-12-31 ILA51.38 Million
≈ $137.75K
+18.93%
2020-12-31 ILA43.20 Million
≈ $115.82K
-12.64%
2019-12-31 ILA49.45 Million
≈ $132.58K
+20.51%
2018-12-31 ILA41.04 Million
≈ $110.02K
+2397.63%
2017-12-31 ILA1.64 Million
≈ $4.40K
-82.03%
2016-12-31 ILA9.14 Million
≈ $24.51K
+9.77%
2015-12-31 ILA8.33 Million
≈ $22.33K
-4.82%
2014-12-31 ILA8.75 Million
≈ $23.46K
--

About Erech Finance Cahalacha Ltd

TA:EFNC Israel Medical Devices
Market Cap
$1.61 Million
ILA599.48 Million ILA
Market Cap Rank
#30217 Global
#445 in Israel
Share Price
ILA236.30
Change (1 day)
+12.26%
52-Week Range
ILA121.00 - ILA305.10
All Time High
ILA730501.20
About

Erech Finance Cahalacha Ltd, together with its subsidiaries, provides loans and credit services to small and medium sized enterprises, associations, and private borrowers in Israel. It is also involved in the development of biomed-drugs in the areas of juvenile diabetes and cancer. The company was founded in 1998 and is based in Jerusalem, Israel.